SUBOXONE (buprenorphine hydrochloride; naloxone hydrochloride) Indivior inc Patent: 8,017,150 Expiration: Feb 13, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug Patent Expirations for the Week of February 12, 2023 appeared first on DrugPatentWatch - Make Better Decisions.